Evolus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolus and other ETFs, options, and stocks.About EOLS
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau.
CEODavid Moatazedi
CEODavid Moatazedi
Employees332
Employees332
HeadquartersNewport Beach, California
HeadquartersNewport Beach, California
Founded2012
Founded2012
Employees332
Employees332
EOLS Key Statistics
Market cap497.11M
Market cap497.11M
Price-Earnings ratio-7.89
Price-Earnings ratio-7.89
Dividend yield—
Dividend yield—
Average volume1.38M
Average volume1.38M
High today$7.91
High today$7.91
Low today$7.43
Low today$7.43
Open price$7.51
Open price$7.51
Volume1.34M
Volume1.34M
52 Week high$17.82
52 Week high$17.82
52 Week low$5.71
52 Week low$5.71
EOLS News
Simply Wall St 4d
Brady Stewart Bought 59% More Shares In EvolusInvestors who take an interest in Evolus, Inc. ( ) should definitely note that the Independent Director, Brady Stewart, recently paid US$6.82 per share to buy U...
TipRanks 4d
Evolus submits Evolysse premarket approval application to FDAEvolus (EOLS) announced that it has submitted the final module of its premarket approval application to the FDA for Evolysse Sculpt, an injectable hyaluronic ac...
TipRanks 6d
Director’s Bold Move: Major Stock Purchase Signals Confidence in EvolusNew insider activity at Evolus ( (EOLS) ) has taken place on August 18, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own EOLS. This list is generated using Robinhood data, and it’s not a recommendation.